doi:10.3969/j.issn.1671-2587.2020.03.002

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2020, Vol. 22 ›› Issue (3): 228-232.DOI: 10.3969/j.issn.1671-2587.2020.03.002

Previous Articles Next Articles

Received:2020-03-09 Online:2020-06-20 Published:2020-06-13

[1] Lu R J,Zhao X,Li J,et al.Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding[J]. Lancet,2020,395(10224):565-574.
[2] 国家卫生健康委办公厅,国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL]. (2020-03-03).http://www.gov.cn/zhengce/zhengceku/2020-03/04/5486705/files/ae61004f930d47598711a0d4cbf874a9.pdf.
[3] 顾燕妮, 沈朝斌, 陈同辛. 人类冠状病毒感染与宿主的相互作用 [J/OL] . 中华实用儿科临床杂志,2020,35 (2020-02-25).http://rs.yiigle.com/yufabiao/1182680.htm.
[4] Channappanavar R,Perlman S.Pathogenic human coronavirus infections:causes and consequences of cytokine storm and immunopathology[J]. Semin Immunopathol,2017,39(5):529-539.
[5] Huang K J,Su I J,Theron M,et al.An interferon-?-related cytokine storm in SARS patients[J]. J Med Virol, 2005,75(2):185-194.
[6] Liu J, Zheng X,Tong Q,et al.Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV,2019-nCoV[EB/OL]. J Med Virol. 2020;1-4.https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25709.
[7] Sun MS,Jin H,Sun X,et al.Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke afterRevascularization Therapy[J]. Oxid Med Cell Longev, 2018, 3804979.
[8] Oda T,Akaike T,Hamamoto T,et al.Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD[J]. Science, 1989,244(4907):974-976.
[9] 宋德坤. 急性肺损伤中氧自由基的来源与损伤机制[J]. 昆明医学院学报,1992,13(1):54-56.
[10] Cheng Y,Wong R,Soo Y O,et al.Use of convalescent plasma therapy in SARS patients in Hong Kong[J]. Eur J Clin Microbiol Infect Dis,2005,24(1):44-46.
[11] Zhou BP,Zhong NS,Guan Y.Treatment with convale-scent plasma for influenza A (H5N1) infection[J]. N Engl J Med, 2007,357(14):1450-1451.
[12] Mair-Jenkins J,Saavedra-Campos M,Baillie J K,et al.The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology:a systematic review and exploratory meta-analysis[J]. J Infect Dis,2015,211(1):80-90.
[13] Marano G,Vaglio S,Pupella S,et al.Convalescent plasma: new evidence for an old therapeutic tool ?[J]. Blood Transfus,2016,14(2) :152-157.
[14] Tsang K,Zhong NS.SARS:pharmacotherapy[J]. Respirology,2003,8(Suppl):S25-S30.
[15] Koch B,Schult-Dietrich P,Büttner S,et al.Lectin affinity plasmapheresis for middle east respiratory syndrome-coronavirus and Marburg virus glycoprotein elimination[J]. Blood Purif,2018,46(2):126-133.
[16] Arabi Y M,Al-Enezi F,Longuere K S, et al.Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia:a survey of physicians[J]. BMC Anesthesiol,2016,16(1):36.
[17] Li Z J,Teng B X,Luo J,et al.Clinical application of therapeutic plasma exchange in the Three Gorges Area[J]. Transfus Apher Sci,2010,43(3):305-308.
[18] Luo MC,Wang WF,Yin WF,et al.Clinical efficacy and mechanism of lymphoplasma exchange in the treatment of Guillain-Barre syndrome[J]. Cell Mol Biol (Noisy-le-grand),2017,63(10):106-115.
[19] Sivakumaran P,Vo A A,Villicana R,et al.Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allografts[J]. J Clin Apher,2009,24(4):155-160.
[20] Leng Z,Zhu R, Hou W,et al. Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia [EB/OL]. Aging and disease, http://www.aginganddisease.org/EN/10.14336/AD.2020.0228.
[21] Liang B, Chen J, Li T, et al. Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cell[EB/OL]. ChinaXiv, (2020-02-27).http://www.chinaxiv.org/abs/202002.00084.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	JIA Yan-jun, ZHAO Xu-ying, WEI Zhen-zhen. Effects of Resveratrol on Platelet Oxidative Stress and Aging Index and Storage Time [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 137-141.
[2]	WANG Hui-ru, LIU Hui-lan. Factors Influencing Blood Transfusion in Patients after Unrelated Umbilical Cord Blood Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 162-166.
[3]	ZHANG Yuan-yuan, YING Mei-ai, PAN Jian, et al. The Clinical Effect of Plasma Exchange in ABO Incompatible Relatives in vivo Kidney Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 167-172.
[4]	WANG Lei, WU Xue-zhong. Retrospective Analysis of Rh (D,C, c, E, e) Antigens Compatibility between Blood Recipients and Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 181-185.
[5]	GAN Shan, DUAN Ling, HU Hong-bing. The Clinical Use of Blood in Exchange Transfusion for Severe Neonatal Hyperbilirubinemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 185-188.
[6]	DUAN Bing-zheng, WANG Shu-lian, LIAN Jun-hui, et al. Clinical Significance of Direct Anti-human Globulin Test in Patients' Blood Transfusion Effect [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 189-191.
[7]	YANG Chun-chen, RONG Rui-ming, LI Yang, et al. An Evaluation Model of Clinical Blood Transfusion Records Based on Cov-AHP-fuzzy Comprehensive Evaluation Method [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 192-196.
[8]	GUO Wei-jie, LIU Ze-ya, ZHANG Fan, et al. Meta-analysis：Unexpected Antibody Positive Rate of Blood Donors in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 202-212.
[9]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 236-239.
[10]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 239-241.
[11]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 248-255.
[12]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 259-262.
[13]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 268-272.
[14]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 13-17.
[15]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 587-589.